News Releases

Date	Title	Document
Date Dec 09, 2024	Title Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings	Document PDF
Date Dec 04, 2024	Title Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study	Document PDF
Date Dec 02, 2024	Title Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms	Document PDF
Date Nov 12, 2024	Title Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025	Document PDF
Date Nov 06, 2024	Title Oncocyte To Announce Third Quarter 2024 Financial Results on Nov. 12	Document PDF
Date Oct 16, 2024	Title Oncocyte Announces Participation in the LD Micro Main Event XVII Conference in Los Angeles	Document PDF
Date Oct 08, 2024	Title Oncocyte’s DetermaIO Immuno-Oncology Assay Predicts Response to Atezolizumab in Phase 2 Clinical Trial	Document PDF
Date Oct 02, 2024	Title Oncocyte Signs Leading Transplant Centers in US and Germany	Document PDF
Date Oct 02, 2024	Title Oncocyte Corporation Announces $10.2 Million Private Placement of Securities Priced At-The-Market Under Nasdaq Rules	Document PDF
Date Aug 12, 2024	Title Oncocyte’s VitaGraft™ Kidney Used to Monitor Effect of Daratumumab on Anti-body Mediated Rejection in New Case Series Study	Document PDF